
Journal of Medicinal Chemistry p. 1295 - 1299 (1984)
Update date:2022-08-05
Topics:
Strazzolini, Paolo
Malabarba, Adriano
Ferrari, Pietro
Grandi, Maria
Cavalleri, Bruno
L-Alanosine <3-(hydroxynitrosoamino)-L-alanine> is an antitumor antibiotic that at the present is undergoing phase II clinical trials.Its mode of action as well as its metabolism has been extensively studied, and the metabolite N-<(5-amino-1-β-D-ribofuran
View MoreMeryer (Shanghai) Chemical Technology Co., Ltd.
website:http://www.meryer.com/cn/index/
Contact:+86-755-86170518
Address:Minhang,Shanghai, China
Chuzhou Baiao Biologhy S&T Co., Ltd.
Contact:+86-25-83212599;+86-25-83212699 13705185959
Address:Room 905, Tianzheng International Platza, No.399, Zhongyang Road ,Nanjing, Jiangsu Province, China
Contact:+44 7958 511245
Address:PO Box 469, Manchester, UK
Contact:13357117572
Address:No.149 Shiji dadao Road.
Global United Biotechnology Inc.
Contact:+86-21-61618568
Address:Room 309, Building 6, NO.135, Jinyu Road, Pudong
Doi:10.1021/op060125+
(2006)Doi:10.1039/b607710b
(2006)Doi:10.1016/j.jorganchem.2006.05.041
(2006)Doi:10.1016/S0040-4020(01)82384-X
(1993)Doi:10.1016/0022-328X(84)80108-4
(1984)Doi:10.1021/jo00193a008
(1984)